May 18, 2023 / 04:00PM GMT
Operator
Good morning, and welcome. Please welcome Head of Teva Investor Relations, Ran Meir.
Ran Meir - Teva Pharmaceutical Industries Limited - Head of IR
Hello, everyone. Thank you for joining us today at Teva Strategy Day 2023. It's great to have you in person here in the New York Stock Exchange, and I want to thank also all the people who are joining us online through the webcast. If you want to follow the slides -- our presentation slides, you can find a copy of the slides on our website at ir.tevapharm.com.
And before we go to view the agenda, I would like you to take a good look on Slide #2. This slide contains important forward-looking statements and additional information about these statements and our non-GAAP financial measures is available on our SEC Forms 10-K and 10-Q.
Now let's go over what we'll cover in the next 2 hours: Richard Francis, our President and CEO, will kick off with a presentation outlining the new strategy; Dr. Eric Hughes, our Head of R&D and Chief Medical Officer, will follow with a deep dive on some of the most
Teva Pharmaceutical Industries Ltd Investor Day Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers